A detailed history of Nearwater Capital Markets, LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Nearwater Capital Markets, LTD holds 150,000 shares of GILD stock, worth $17.6 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
150,000
Holding current value
$17.6 Million
% of portfolio
0.27%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$96.91 - $113.0 $14.5 Million - $17 Million
150,000 New
150,000 $16.6 Billion

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $147B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Nearwater Capital Markets, LTD Portfolio

Follow Nearwater Capital Markets, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nearwater Capital Markets, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nearwater Capital Markets, LTD with notifications on news.